Autoimmune connective tissue diseases and pregnancy

Area of Science:

• Rheumatology
• Obstetrics
• Dermatology

Background:

• Autoimmune connective tissue diseases (ACTDs) disproportionately affect women.
• These conditions necessitate a multidisciplinary approach involving dermatologists and other specialists.
• Pregnancy in ACTD patients presents significant risks to both mother and fetus.

Purpose of the Study:

• To highlight the complexities of pregnancy in women with ACTDs.
• To emphasize the need for careful therapeutic choices during pregnancy.
• To outline key strategies for achieving successful pregnancy outcomes in this population.

Main Methods:

• Review of existing literature on ACTDs and pregnancy.
• Emphasis on multidisciplinary team collaboration.
• Discussion of risk assessment and management strategies.

Main Results:

• Pregnancy in ACTD patients is associated with potential disease exacerbation in mothers.
• Increased fetal morbidity and mortality risks are present.
• Drug selection requires careful consideration due to teratogenic potential.

Conclusions:

• Decision to conceive requires thorough evaluation of disease type, stage, and patient's clinical status.
• Effective counseling, close monitoring, and tailored management are essential.
• Optimal pregnancy outcomes are achievable through a comprehensive, risk-stratified, multidisciplinary approach.